Clearance Summary
CELSITE IMPLANTABLE PORT WITH VALVED CATHETER received FDA 510(k) clearance under submission number K993024, sponsored by B. Braun of America, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2000-03-13.
- Submission: K993024
- Applicant / Sponsor: B. Braun of America, Inc.
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5965
- Decision date: 2000-03-13
Classification & Regulation
This clearance is catalogued under FDA product code LJT and 21 CFR 880.5965, within the General Hospital review panel as a Class II device.